{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:37:57Z","timestamp":1776893877313,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spontaneous bacterial peritonitis (SBP) is one of the most common infectious diseases in patients with cirrhosis and is associated with serious prognosis. A prevailing dogma posits that SBP is exacerbated by the frequent use of proton pump inhibitors (PPIs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>To re-assess the association between PPIs use and SBP incidence with larger and better-quality data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>The studies were identified by searching Proquest, Medline, and Embase for English language articles published between January 2008 and March 2020 using the following keywords alone or in combination: anti-ulcer agent, antacid, proton pump inhibitor, proton pumps, PPI, omeprazole, rabeprazole, lansoprazole, pantoprazole, esomeprazole, peritonitis, spontaneous bacterial peritonitis, SBP, ascites, cirrhosis, ascitic and cirrhotic. Three authors critically reviewed all of the studies retrieved and selected those judged to be the most relevant. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was followed. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Sub-group analyses were done to decrease the heterogeneity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of twenty-three studies: seven case\u2013control, and sixteen cohorts, involving 10,386 patients were analyzed. The overall results showed a statistically significant association between SBP and PPIs use (pooled odds ratio (OR): 1.80, 95% CI of 1.41 to 2.31). Substantial heterogeneity was observed. On subgroup analysis involving cohort studies, the association was weaker (OR: 1.55 with 95% CI of 1.16 to 2.06 <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001) but still statistically significant and with high heterogeneity (Chi<jats:sup>2<\/jats:sup>p\u2009=\u200957.68; <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u200974%). For case\u2013control studies, the OR was 2.62 with a 95% CI of 1.94 to 3.54. The funnel plot was asymmetric and Egger\u2019s test confirmed asymmetry suggesting publication bias (intercept\u2009= \u2212 0.05, SE\u2009=\u20090.27, P\u2009=\u20090.850 two-tailed).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This meta-analysis sheds light on the conflicting results raised by previous studies regarding the association of SBP with PPIs use. Our meta-analysis showed that there is a weak association, although statistically significant, between SBP and PPIs use. However, the magnitude of the possible association diminished when analysis focused on higher quality data that were more robust. Thus, this updated meta-analysis suggests judicious use of PPIs among cirrhotic patients with ascites.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13099-021-00414-8","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T13:03:48Z","timestamp":1616159028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4552-4513","authenticated-orcid":false,"given":"Saad","family":"Alhumaid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9471-2767","authenticated-orcid":false,"given":"Abbas","family":"Al Mutair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Al Alawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Rehman Zia","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali A.","family":"Rabaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyaa","family":"Elhazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awad","family":"Al-Omari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"issue":"980","key":"414_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/pgmj.2006.056168","volume":"83","author":"A Koulaouzidis","year":"2007","unstructured":"Koulaouzidis A, Bhat S, Karagiannidis A, Tan W, Linaker B. Spontaneous bacterial peritonitis. Postgrad Med J. 2007;83(980):379\u201383.","journal-title":"Postgrad Med J"},{"issue":"8","key":"414_CR2","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/j.1572-0241.2003.07600.x","volume":"98","author":"BA Runyon","year":"2003","unstructured":"Runyon BA. The evolution of ascitic fluid analysis in the diagnosis of spontaneous bacterial peritonitis. Am J Gastroenterol. 2003;98(8):1675.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"414_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fern\u00e1ndez","year":"2002","unstructured":"Fern\u00e1ndez J, Navasa M, G\u00f3mez J, Colmenero J, Vila J, Arroyo V, Rod\u00e9s J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35(1):140\u20138.","journal-title":"Hepatology"},{"issue":"3","key":"414_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cgh.2010.11.038","volume":"9","author":"P Tandon","year":"2011","unstructured":"Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2011;9(3):260\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"414_CR5","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/S0168-8278(97)80474-6","volume":"26","author":"C Guarner","year":"1997","unstructured":"Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol. 1997;26(6):1372\u20138.","journal-title":"J Hepatol"},{"issue":"4","key":"414_CR6","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1053\/he.2000.5746","volume":"31","author":"A Pardo","year":"2000","unstructured":"Pardo A, Bartol\u00ed R, Lorenzo-Z\u00fa\u00f1iga V, Planas R, Vi\u00f1ado B, Riba J, Cabr\u00e9 E, Santos J, Luque T, Ausina V. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology. 2000;31(4):858\u201363.","journal-title":"Hepatology"},{"issue":"4","key":"414_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cgh.2011.11.019","volume":"10","author":"GA Goel","year":"2012","unstructured":"Goel GA, Deshpande A, Lopez R, Hall GS, van Duin D, Carey WD. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol. 2012;10(4):422\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"414_CR8","doi-asserted-by":"crossref","unstructured":"Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Summereder C, Hagmann M, Blacky A, Ferlitsch A, Sieghart W. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites. PLoS ONE. 2014;9(11).","DOI":"10.1371\/journal.pone.0110503"},{"issue":"4","key":"414_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cgh.2014.07.060","volume":"13","author":"JG O'Leary","year":"2015","unstructured":"O\u2019Leary JG, Reddy KR, Wong F, Kamath PS, Patton HM, Biggins SW, Fallon MB, Garcia-Tsao G, Subramanian RM, Malik R. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clinical Gastroenterol Hepatol. 2015;13(4):753-9.e2.","journal-title":"Clinical Gastroenterol Hepatol"},{"issue":"6","key":"414_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1155\/2014\/751921","volume":"28","author":"M Ratelle","year":"2014","unstructured":"Ratelle M, Perreault S, Villeneuve J-P, Tremblay L. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites. Canadian J Gastroenterol Hepatol. 2014;28(6):330\u20134.","journal-title":"Canadian J Gastroenterol Hepatol"},{"issue":"5","key":"414_CR11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jhep.2014.11.036","volume":"62","author":"R Terg","year":"2015","unstructured":"Terg R, Casciato P, Garbe C, Cartier M, Stieben T, Mendizabal M, Niveyro C, Benavides J, Marino M, Colombato L. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. J Hepatol. 2015;62(5):1056\u201360.","journal-title":"J Hepatol"},{"issue":"11","key":"414_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/MEG.0000000000000448","volume":"27","author":"MA Khan","year":"2015","unstructured":"Khan MA, Kamal S, Khan S, Lee WM, Howden CW. Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol. 2015;27(11):1327\u201336.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"414_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.dld.2015.12.009","volume":"48","author":"T Yu","year":"2016","unstructured":"Yu T, Tang Y, Jiang L, Zheng Y, Xiong W, Lin L. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: a meta-analysis. Dig Liver Dis. 2016;48(4):353\u20139.","journal-title":"Dig Liver Dis"},{"issue":"2","key":"414_CR14","first-page":"1227","volume":"9","author":"H Dong","year":"2016","unstructured":"Dong H, Luo S, Dong Y, Feng W, Wei Y. The use of PPI is associated with spontaneous bacterial peritonitis in cirrhotic patients of different ethnic groups: a meta-analysis. Int J Clin Exp Med. 2016;9(2):1227\u201335.","journal-title":"Int J Clin Exp Med"},{"key":"414_CR15","unstructured":"Wells GA, Tugwell P, O\u2019Connell D, Welch V, Peterson J, Shea B, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2015."},{"issue":"7","key":"414_CR16","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"7136","key":"414_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1136\/bmj.316.7136.989","volume":"316","author":"HTO Davies","year":"1998","unstructured":"Davies HTO, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ. 1998;316(7136):989\u201391.","journal-title":"BMJ"},{"issue":"11","key":"414_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"7414","key":"414_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"7109","key":"414_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"5","key":"414_CR21","doi-asserted-by":"publisher","first-page":"S-946","DOI":"10.1016\/S0016-5085(12)63667-1","volume":"142","author":"A Aditi","year":"2012","unstructured":"Aditi A, Crippin JS, Abhishek A. Sa1014 Role of proton pump inhibitors in the development of spontaneous bacterial peritonitis amongst cirrhotics; a retrospective cohort study. Gastroenterol. 2012;142(5):S-946.","journal-title":"Gastroenterol"},{"issue":"5","key":"414_CR22","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/ajg.2009.80","volume":"104","author":"JS Bajaj","year":"2009","unstructured":"Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol. 2009;104(5):1130\u20134.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"414_CR23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s10620-007-9899-9","volume":"53","author":"MS Campbell","year":"2008","unstructured":"Campbell MS, Obstein K, Reddy KR, Yang Y-X. Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci. 2008;53(2):394\u20138.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"414_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3109\/00365521.2011.551891","volume":"46","author":"EJ Choi","year":"2011","unstructured":"Choi EJ, Lee HJ, Kim KO, Lee SH, Eun JR, Jang BI, Kim TN. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites. Scand J Gastroenterol. 2011;46(5):616\u201320.","journal-title":"Scand J Gastroenterol"},{"issue":"11\u201312","key":"414_CR25","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/apt.13827","volume":"44","author":"H Cole","year":"2016","unstructured":"Cole H, Pennycook S, Hayes P. The impact of proton pump inhibitor therapy on patients with liver disease. Aliment Pharmacol Ther. 2016;44(11\u201312):1213\u201323.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"414_CR26","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/hep.28737","volume":"64","author":"G Dam","year":"2016","unstructured":"Dam G, Vilstrup H, Watson H, Jepsen P. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology. 2016;64(4):1265\u201372.","journal-title":"Hepatology"},{"issue":"9","key":"414_CR27","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/liv.12210","volume":"33","author":"M de Vos","year":"2013","unstructured":"de Vos M, De Vroey B, Garcia BG, Roy C, Kidd F, Henrion J, Deltenre P. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Liver Int. 2013;33(9):1316\u201323.","journal-title":"Liver Int"},{"issue":"2","key":"414_CR28","first-page":"83","volume":"26","author":"A-N Elzouki","year":"2019","unstructured":"Elzouki A-N, Neffati N, Rasoul FA, Abdallah A, Othman M, Waness A. Increased risk of Spontaneous bacterial peritonitis in cirrhotic patients using proton pump inhibitors GE-Portuguese. J Gastroenterol. 2019;26(2):83\u20139.","journal-title":"J Gastroenterol"},{"key":"414_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejim.2016.04.016","volume":"32","author":"K-W Huang","year":"2016","unstructured":"Huang K-W, Kuan Y-C, Luo J-C, Lin C-L, Liang J-A, Kao C-H. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis. Eur J Intern Med. 2016;32:91\u20135.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"414_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MEG.0000000000001499","volume":"32","author":"T Janka","year":"2020","unstructured":"Janka T, Tornai T, Borb\u00e9ly B, Tornai D, Altorjay I, Papp M, Vit\u00e1lis Z. Deleterious effect of proton pump inhibitors on the disease course of cirrhosis. Eur J Gastroenterol Hepatol. 2020;32(2):257\u201364.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"414_CR31","doi-asserted-by":"crossref","unstructured":"Khan TU, Khan W, Iqbal S. Frequency of spontaneous bacterial peritonintis in chronic liver disease patients using proton pump inhibitors. Professional Medical Journal. 2020;27(3).","DOI":"10.29309\/TPMJ\/2020.27.03.968"},{"issue":"5","key":"414_CR32","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/jgh.13637","volume":"32","author":"JH Kim","year":"2017","unstructured":"Kim JH, Lim KS, Min YW, Lee H, Min BH, Rhee PL, Kim JJ, Koh KC, Paik SW. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis. J Gastroenterol Hepatol. 2017;32(5):1064\u201370.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"414_CR33","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/jgh.12426","volume":"29","author":"JH Kwon","year":"2014","unstructured":"Kwon JH, Koh SJ, Kim W, Jung YJ, Kim JW, Kim BG, Lee KL, Im JP, Kim YJ, Kim JS. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis. J Gastroenterol Hepatol. 2014;29(4):775\u201381.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"414_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/apt.12875","volume":"40","author":"Y Min","year":"2014","unstructured":"Min Y, Lim K, Min BH, Gwak GY, Paik Y, Choi M, Lee J, Kim J, Koh K, Paik S. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study. Aliment Pharmacol Ther. 2014;40(6):695\u2013704.","journal-title":"Aliment Pharmacol Ther"},{"issue":"35","key":"414_CR35","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.4254\/wjh.v9.i35.1278","volume":"9","author":"SA Miozzo","year":"2017","unstructured":"Miozzo SA, John JA, Appel-da-Silva MC, Dossin IA, Tovo CV, Mattos AA. Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis. World J Hepatol. 2017;9(35):1278.","journal-title":"World J Hepatol"},{"issue":"10","key":"414_CR36","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2169\/internalmedicine.53.2021","volume":"53","author":"K Miura","year":"2014","unstructured":"Miura K, Tanaka A, Yamamoto T, Adachi M, Takikawa H. Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis. Intern Med. 2014;53(10):1037\u201342.","journal-title":"Intern Med"},{"issue":"2","key":"414_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.18203\/2320-6012.ijrms20190338","volume":"7","author":"A Rajender","year":"2019","unstructured":"Rajender A, Choudhary P, Mathur S, Bhargava R, Upadhyay S, Nepalia S. Proton pump inhibitor: a risk factor for spontaneous bacterial peritonitis in Indian cirrhotics decompensated with ascites. Int J Res Med Sci. 2019;7(2):378.","journal-title":"Int J Res Med Sci"},{"issue":"2","key":"414_CR38","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/apt.13873","volume":"45","author":"L Schiavon","year":"2017","unstructured":"Schiavon L, Silva T, Fischer J, Narciso-Schiavon J. proton pump inhibitors and prognosis of cirrhosis\u2013searching for the balance point. Aliment Pharmacol Ther. 2017;45(2):378\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"414_CR39","doi-asserted-by":"crossref","unstructured":"Welage LS, Berardi RR. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. Journal of the American Pharmaceutical Association (1996). 2000;40(1):52\u201362.","DOI":"10.1016\/S1086-5802(16)31036-1"},{"key":"414_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejim.2016.10.007","volume":"37","author":"V Savarino","year":"2017","unstructured":"Savarino V, Dulbecco P, de Bortoli N, Ottonello A, Savarino E. The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal. Eur J Intern Med. 2017;37:19\u201324.","journal-title":"Eur J Intern Med"},{"issue":"19","key":"414_CR41","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.3748\/wjg.14.2980","volume":"14","author":"F Lodato","year":"2008","unstructured":"Lodato F, Azzaroli F, Di Girolamo M, Feletti V, Cecinato P, Lisotti A, Festi D, Roda E, Mazzella G. Proton pump inhibitors in cirrhosis: tradition or evidence based practice? World J Gastroenterol. 2008;14(19):2980.","journal-title":"World J Gastroenterol"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-021-00414-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-021-00414-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-021-00414-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T17:06:10Z","timestamp":1620925570000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-021-00414-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["414"],"URL":"https:\/\/doi.org\/10.1186\/s13099-021-00414-8","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"17"}}